Statement on Pertussis vaccine

Diphtheria toxoid, tetanus toxoid, pertussis vaccine (children <7 years old), Haemophilus influenzae type b conjugate, 23- valent pneumococcal polysaccharide, inactivated

We evaluated the functional activity of Haemophilus influenzae B (Hib) antibodies elicited in a group of infants immunized with the diphtheria-tetanus-pertussis vaccine combined

New developments include a pertussis vaccine that can be produced at the same price as the traditional vaccine by a process that also yields an adjuvant that increases the

Safety and immunogenicity of a Haemophilus influenza type b polysaccharide – tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccine in thai

Preventing teta- nus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the

Methods: The monthly recorded total number of diphtheria and tetanus toxoids and pertussis vaccine (alone or in combination with the Haemophilus inluenzae type b conjugate

Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort.. Clin